We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Mylan

News List

With EpiPen competitors bearing down, can Mylan maintain its lead? fiercepharma
September 20, 2018
The emergency epinephrine market is about to be flush with options. At least three new epinephrine marketers are challenging Mylan’s EpiPen, the longtime market leader still reeling after a price-hike debacle in 2016 and ...
US FDA approves Mylan’s copy of Allergan’s vaginal cream expressbpd
January 03, 2018
Vaginal atrophy results in thinning and inflammation of the vaginal walls due to less estrogen
Mylan-Biocon’s breast cancer biosimilar gets ANVISA nod expressbpd
January 02, 2018
Biocon and Mylan’s proposed biosimilar trastuzumab has been approved by Brazilian regulatory agency ANVISA, through their partner Libbs Farmaceutica (Libbs).